Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen
Phone:
202-334-2183
Fax:
202-334-2843
E-mail:
dkorsen@nas.edu

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

Selected Filters

    • Topic: Biomedical and Health Research [Remove]
    • Topic: Health Services, Coverage, and Access [Remove]

Filter News

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.


News Release

Press Release: Urgent Change Needed to Improve Diagnosis in Health Care or Diagnostic Errors Will Likely Worsen, Says New Report
Released: 9/22/2015

Most people will experience at least one diagnostic error -- an inaccurate or delayed diagnosis -- in their lifetime, sometimes with devastating consequences, says a new report from the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine.

Report at a Glance

  • Figures (HTML)
  • Report in Brief (PDF)
  • List of Recommendations (PDF)
  • Resources for Improving Communication (PDF)
  • Resources for Improving Communication (Spanish) (PDF)
  • Cover Image and Citation Slide (HTML)
Reports: Related Reports
Activities: Related Activities

News Release

Health Care Wait Times Vary Greatly Throughout U.S.; New IOM Report Calls for Putting Patients and Families First Using Approaches Applied Successfully in Other Sectors
Released: 6/29/2015

Tremendous variability in wait times for health care appointments exists throughout the U.S., ranging from same day service to several months, says a new report from the Institute of Medicine.

Report at a Glance

  • Report Brief (PDF)
  • Key-Findings-Recommendations (PDF)
  • Key Principles (PDF)
Reports: Related Reports
Activities: Related Activities

Announcement

What You Read in 2013

A list of the most viewed IOM reports for the year 2013.

Reports: Related Reports
Activities: Related Activities

Actions Taken

National Cancer Institute Develops Checklist to Determine Readiness of an Omics Test

The National Cancer Institute (NCI) developed a checklist with 30 criteria for determining the readiness of an omics test for use in guiding patient care in clinical trials, based on the principles set forth in the IOM report Evolution of Translational Omics: Lessons Learned and the Path Forward. The checklist will be used when reviewing proposals for NCI-sponsored clinical trials in which omics tests will guide care.

Report at a Glance

Reports: Related Reports
Activities: Related Activities

Announcement

What You Read 2012

A list of the most viewed IOM reports for the year 2012.

Reports: Related Reports
Activities: Related Activities

Actions Taken

NIH Creates Office of Emergency Care Research

Sparked by the release of three 2006 IOM reports – Emergency Care for Children: Growing Pains, Hospital-Based Emergency Care: At the Breaking Point, and Emergency Medical Services At the Crossroads – the NIH began an effort to examine its research activities in emergency medicine and to hear from investigators and stakeholders in the field. The IOM reports found the emergency medical system to be overburdened, underfunded, and highly fragmented. The NIH effort led to the creation in 2012 of the Office of Emergency Care Research.

Reports: Related Reports
Activities: Related Activities

News Release

IOM Report Recommends Evaluation and Validation Process to Prevent Problems Associated With Turning 'Omics' Research Into Clinical Tests
Released: 3/23/2012

Genomics, proteomics, and other branches of molecular bioscience offer the prospect of greater precision in medical care, but some clinical tests based on "omics" research have proved invalid and highlighted the challenges of dealing with complex data. To enhance the translation of omics-based discoveries to clinical use, a new report by the Institute of Medicine recommends a detailed process to evaluate whether the data and computational steps underlying such tests are sound and the tests are ready to be used in clinical trials. The proposed process defines responsibilities and best practices for the investigators, research institutions, funders, regulators, and journals involved in development and dissemination of clinical omics-based technologies.

Report at a Glance

Reports: Related Reports
Activities: Related Activities

Media Advisory

IOM Report on Improving “Omics-Based” Test Development Releases March 23
Released: 3/21/2012

Genomics, proteomics, and other branches of molecular bioscience offer the possibility of greater precision in medical care by tailoring therapies to patients' genetic or molecular profiles. But some clinical tests based on "omics" research, including tests developed by researchers at Duke University to select chemotherapy for cancer patients, have proved invalid. Evolution of Translational Omics: Lessons Learned and the Path Forward, a new report from the Institute of Medicine, recommends steps to help avoid future problems associated with moving omics-based discoveries from the lab to clinical settings.

Reports: Related Reports
Activities: Related Activities

Announcement

What You're Reading - February 2012

A list of the most viewed IOM reports for the month of February, 2012.

Reports: Related Reports
Activities: Related Activities

Announcement

What You're Reading - January 2012

A list of the most viewed IOM reports for the month of January, 2012.

Reports: Related Reports
Activities: Related Activities